Cancer BiologybioRxiv
Biomarker-based outcome prediction in prostate adenocarcinoma depends on the TMPRSS2-ERG status
J. S. Gerke, M. F. Orth, Y. Tolkach…·T. G. P. Grunewald
This study identifies subtype-specific prognostic biomarkers in prostate adenocarcinoma, showing that their prognostic value depends on TMPRSS2-ERG fusion status.
DOI 10.1002/ijc.32792